Charles E. Protzman

829 total citations
19 papers, 657 citations indexed

About

Charles E. Protzman is a scholar working on Pharmacology, Molecular Biology and Ophthalmology. According to data from OpenAlex, Charles E. Protzman has authored 19 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 7 papers in Molecular Biology and 5 papers in Ophthalmology. Recurrent topics in Charles E. Protzman's work include Inflammatory mediators and NSAID effects (11 papers), Glaucoma and retinal disorders (5 papers) and Nitric Oxide and Endothelin Effects (4 papers). Charles E. Protzman is often cited by papers focused on Inflammatory mediators and NSAID effects (11 papers), Glaucoma and retinal disorders (5 papers) and Nitric Oxide and Endothelin Effects (4 papers). Charles E. Protzman collaborates with scholars based in United States, Ireland and Italy. Charles E. Protzman's co-authors include David F. Woodward, Achim H.‐P. Krauss, A L Nieves, Linda S. Williams, Robert M. Burk, D.F. Woodward, Clayton S. Spada, S B Hawley, Yuanbo Liang and Karen M. Kedzie and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Charles E. Protzman

19 papers receiving 641 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles E. Protzman United States 13 297 232 189 113 104 19 657
S. Lake Sweden 11 96 0.3× 141 0.6× 310 1.6× 49 0.4× 87 0.8× 28 652
Shouxi Xu United States 17 124 0.4× 246 1.1× 297 1.6× 227 2.0× 115 1.1× 31 807
L. David Waterbury United States 14 204 0.7× 296 1.3× 141 0.7× 104 0.9× 66 0.6× 39 723
Sardar Y.K. Yousufzai United States 16 74 0.2× 277 1.2× 350 1.9× 74 0.7× 222 2.1× 40 708
Yasutaka Takagi Japan 10 42 0.1× 187 0.8× 221 1.2× 87 0.8× 73 0.7× 20 475
Ismail Kaddour‐Djebbar United States 17 41 0.1× 144 0.6× 405 2.1× 61 0.5× 76 0.7× 25 695
Frederic Stern United States 13 39 0.1× 79 0.3× 265 1.4× 31 0.3× 102 1.0× 18 622
Alessandro Bagnis Italy 14 72 0.2× 822 3.5× 353 1.9× 87 0.8× 43 0.4× 29 1.1k
Andrea Matteucci Italy 15 44 0.1× 171 0.7× 314 1.7× 14 0.1× 162 1.6× 31 629
Mohammed Bensaïd France 7 274 0.9× 36 0.2× 181 1.0× 6 0.1× 125 1.2× 11 569

Countries citing papers authored by Charles E. Protzman

Since Specialization
Citations

This map shows the geographic impact of Charles E. Protzman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Protzman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Protzman more than expected).

Fields of papers citing papers by Charles E. Protzman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles E. Protzman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Protzman. The network helps show where Charles E. Protzman may publish in the future.

Co-authorship network of co-authors of Charles E. Protzman

This figure shows the co-authorship network connecting the top 25 collaborators of Charles E. Protzman. A scholar is included among the top collaborators of Charles E. Protzman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles E. Protzman. Charles E. Protzman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Woodward, David F., Achim H.‐P. Krauss, Charles E. Protzman, et al.. (2006). Identification of an antagonist that selectively blocks the activity of prostamides (prostaglandin‐ethanolamides) in the feline iris. British Journal of Pharmacology. 150(3). 342–352. 51 indexed citations
2.
Matias, Isabel, Vincenzo Di Marzo, Tiziana Bisogno, et al.. (2004). STUDIES ON THE IN VITRO PHARMACOLOGY AND METABOLISM OF PROSTAGLANDIN–ETHANOLAMIDES (PROSTAMIDES) IN THE FELINE IRIS. Investigative Ophthalmology & Visual Science. 45(13). 1036–1036. 1 indexed citations
3.
Matias, Isabel, Luciano De Petrocellis, Tiziana Bisogno, et al.. (2004). Prostaglandin Ethanolamides (Prostamides): In Vitro Pharmacology and Metabolism. Journal of Pharmacology and Experimental Therapeutics. 309(2). 745–757. 116 indexed citations
4.
Spada, Clayton S., Achim H.‐P. Krauss, David F. Woodward, et al.. (2004). Bimatoprost and prostaglandin F2α selectively stimulate intracellular calcium signaling in different cat iris sphincter cells. Experimental Eye Research. 80(1). 135–145. 33 indexed citations
5.
Li, Chen, et al.. (2003). Comparison of Prostaglandin F2α, Bimatoprost (Prostamide), and Butaprost (EP2 Agonist) on Cyr61 and Connective Tissue Growth Factor Gene Expression. Journal of Biological Chemistry. 278(29). 27267–27277. 66 indexed citations
6.
Woodward, David F., Achim H.‐P. Krauss, Yuanbo Liang, et al.. (2003). Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024). Journal of Pharmacology and Experimental Therapeutics. 305(2). 772–785. 115 indexed citations
7.
Evinger, Albert J., et al.. (2003). Comparison of PGF2, Bimatoprost (Prostamide) and Butaprost (EP2 AGONIST) on Cyr61 and CTGF Gene Expression. 44(13). 4392–4392. 1 indexed citations
8.
Liang, Yuanbo, et al.. (2002). Upregulation of Regulator of G Protein Signaling 5 (RGS5) in the Iris-Ciliary Body of Chronic Ocular Hypertensive Primates. Investigative Ophthalmology & Visual Science. 43(13). 3387–3387. 1 indexed citations
9.
Fujino, Hiromichi, Kristen L. Pierce, Dinesh Kumar Srinivasan, et al.. (2000). Delayed Reversal of Shape Change in Cells Expressing FPB Prostanoid Receptors. Journal of Biological Chemistry. 275(38). 29907–29914. 31 indexed citations
10.
Krauss, Achim H.‐P., David F. Woodward, Robert M. Burk, et al.. (1997). Pharmacological Evidence for Thromboxane Receptor Heterogeneity—Implications for the Eye. Journal of Ocular Pharmacology and Therapeutics. 13(4). 303–312. 9 indexed citations
11.
Krauss, Achim H.‐P., David F. Woodward, Linda L. Gibson, et al.. (1996). Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11‐cyclic carbonate derivatives of prostaglandin F2α. British Journal of Pharmacology. 117(6). 1171–1180. 19 indexed citations
12.
Krauss, Achim H.‐P., David F. Woodward, Linda L. Gibson, et al.. (1995). AGN 191976: A Novel Thromboxane A 2 -Mimetic with Ocular Hypotensive Properties. Journal of Ocular Pharmacology and Therapeutics. 11(3). 203–212. 9 indexed citations
13.
Woodward, D.F., Craig Fairbairn, Achim H.‐P. Krauss, Ruth A. Lawrence, & Charles E. Protzman. (1995). Radioligand binding analysis of receptor subtypes in two FP receptor preparations that exhibit different functional rank orders of potency in response to prostaglandins.. Journal of Pharmacology and Experimental Therapeutics. 273(1). 285–291. 19 indexed citations
14.
Burk, Robert M., Michael E. Garst, Linda L. Gibson, et al.. (1994). Synthesis of a novel series of 3-oxo-2,4-dioxobicyclo[3.2.1]octanes: additional evidence for two thromboxane receptor subtypes.. Bioorganic & Medicinal Chemistry Letters. 4(17). 2103–2106. 2 indexed citations
15.
Chan, Moon Fai, et al.. (1994). Studies on a novel series of acyl ester prodrugs of prostaglandin F2 alpha.. British Journal of Ophthalmology. 78(7). 560–567. 17 indexed citations
16.
Woodward, D.F., Charles E. Protzman, Achim H.‐P. Krauss, & Linda S. Williams. (1993). Identification of 19 (R)-OH prostaglandin E2 as a selective prostanoid EP2-receptor agonist. Prostaglandins. 46(4). 371–383. 31 indexed citations
17.
Woodward, David F., Clayton S. Spada, S B Hawley, et al.. (1993). Further studies on ocular responses to DP receptor stimulation. European Journal of Pharmacology. 230(3). 327–333. 30 indexed citations
18.
Woodward, David F., S B Hawley, Linda S. Williams, et al.. (1990). Studies on the ocular pharmacology of prostaglandin D2.. PubMed. 31(1). 138–46. 72 indexed citations
19.
Protzman, Charles E. & David F. Woodward. (1990). Prostanoid-induced blood-aqueous barrier breakdown in rabbits involves the EP2 receptor subtype.. PubMed. 31(11). 2463–6. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Lake Breakdown of academic impact, for papers by Shouxi Xu Breakdown of academic impact, for papers by L. David Waterbury Breakdown of academic impact, for papers by Sardar Y.K. Yousufzai Breakdown of academic impact, for papers by Yasutaka Takagi Breakdown of academic impact, for papers by Ismail Kaddour‐Djebbar Breakdown of academic impact, for papers by Frederic Stern Breakdown of academic impact, for papers by Alessandro Bagnis Breakdown of academic impact, for papers by Andrea Matteucci Breakdown of academic impact, for papers by Mohammed Bensaïd
Rankless by CCL
2026